BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Nicole Brenner, Alexander J. Mentzer, Julia Butt, Kathrin L. Braband, Angelika Michel, Katie Jeffery, Paul Klenerman, Barbara Gärtner, Paul Schnitzler, Adrian Hill, Graham Taylor, Maria A. Demontis, Edward Guy, Stephen J. Hadfield, Rachael Almond, Naomi Allen, Michael Pawlita, Tim Waterboer, Isabelle Chemin. Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondiiPLOS ONE 2019; 14(1): e0210407 doi: 10.1371/journal.pone.0210407
2
Nativa Helena Alves Del‐Rios, Lyriane Apolinário Araujo, Regina Maria Bringel Martins, Rafael Alves Guimarães, Márcia Alves Dias Matos, Karlla Antonieta Amorim Caetano, Raquel Silva Pinheiro, Divânia Dias Silva França, Leandro Nascimento Silva, Sheila Araújo Teles, Megmar Aparecida Santos Carneiro. Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine usersJournal of Medical Virology 2019;  doi: 10.1002/jmv.25632
3
Rehab I Moustafa, Jean Dubuisson, Muriel Lavie. Function of the HCV E1 envelope glycoprotein in viral entry and assemblyFuture Virology 2019; 14(3): 171 doi: 10.2217/fvl-2018-0180
4
Shahab Mahmoudvand, Somayeh Shokri, Reza Taherkhani, Fatemeh Farshadpour. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(1): 42-58 doi: 10.3748/wjg.v25.i1.42
5
Vadim A. Shiryaev, Eugene V. Radchenko, Vladimir A. Palyulin, Nikolay S. Zefirov, Nikolay I. Bormotov, Olga A. Serova, Larisa N. Shishkina, Marat R. Baimuratov, Kseniya M. Bormasheva, Yulia A. Gruzd, Elena A. Ivleva, Marina V. Leonova, Anton V. Lukashenko, Dmitry V. Osipov, Vitaliy A. Osyanin, Alexander N. Reznikov, Vera A. Shadrikova, Anastasia E. Sibiryakova, Ilya M. Tkachenko, Yuri N. Klimochkin. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channelsEuropean Journal of Medicinal Chemistry 2018; 158: 214 doi: 10.1016/j.ejmech.2018.08.009
6
J Sira, M Brown, S Ambegaokar, L Modin, DA Kelly. The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United KingdomJournal of Child Health Care 2019; 23(3): 437 doi: 10.1177/1367493519831499
7
Rehab I. Moustafa, Juliano G. Haddad, Lydia Linna, Xavier Hanoulle, Véronique Descamps, Ahmed Atef Mesalam, Thomas F. Baumert, Gilles Duverlie, Philip Meuleman, Jean Dubuisson, Muriel Lavie, J.-H. James Ou. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 EctodomainJournal of Virology 2018; 92(20) doi: 10.1128/JVI.00939-18
8
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, María Elena Gómez-Torres, Rosa María Ribas-Aparicio, María de la Luz Martínez-Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencingJournal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
9
Bridget Williams, Jessica Howell, Joseph Doyle, Alexander J. Thompson, Bridget Draper, Chloe Layton, Ned Latham, Frances Bramwell, Dean Membrey, Maggie Mcpherson, Janine Roney, Mark Stoové, Margaret E. Hellard, Alisa Pedrana. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility studyInternational Journal of Drug Policy 2019; 72: 91 doi: 10.1016/j.drugpo.2019.05.012
10
Melanie R. Walker, Preston Leung, Auda A. Eltahla, Alexander Underwood, Arunasingam Abayasingam, Nicholas A. Brasher, Hui Li, Bing-Ru Wu, Lisa Maher, Fabio Luciani, Andrew R. Lloyd, Rowena A. Bull. Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodiesScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49454-w
11
Carolina Coutinho, Leonardo S. Bastos, Jurema Corrêa da Mota, Lidiane Toledo, Katia Costa, Neilane Bertoni, Francisco I. Bastos. The risks of HCV infection among Brazilian crack cocaine users: incorporating diagnostic test uncertaintyScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-35657-0
12
Hoda El Aggan, Nahla Farahat, Nevine El Deeb, Ahmed Zeid, Assem El-Shendidi. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injuryMicrobial Pathogenesis 2019; 131: 65 doi: 10.1016/j.micpath.2019.03.032
13
B. Dominguez-Molina, K. Machmach, C. Perales, L. Tarancon-Diez, I. Gallego, J. L. Sheldon, M. Leal, E. Domingo, E. Ruiz-Mateos, Bryan R. G. Williams. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic CellsJournal of Virology 2018; 92(23) doi: 10.1128/JVI.01219-18
14
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitisEuropean Journal of Gastroenterology & Hepatology 2018; 30(11): 1277 doi: 10.1097/MEG.0000000000001254
15
Yin Liu, Xia Zou, Wen Chen, Cheng Gong, Li Ling. Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational StudyInternational Journal of Environmental Research and Public Health 2019; 16(22): 4436 doi: 10.3390/ijerph16224436
16
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in AmmanBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
17
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic reviewJournal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
18
Muriel Lavie, Xavier Hanoulle, Jean Dubuisson. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing AntibodiesFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00910
19
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesisJournal of Cellular Physiology 2019; 234(9): 14734 doi: 10.1002/jcp.28249
20
A. B. Damola, J. A. Adeniji, A. S. Bakarey. Hepatitis C virus seropositivity and the risk factors for transmission among blood donors in some selected centers in Lagos State, Southwest NigeriaJournal of Immunoassay and Immunochemistry 2019; 40(5): 528 doi: 10.1080/15321819.2019.1647853
21
Meryem Jefferies, Bisma Rauff, Harunor Rashid, Thao Lam, Shafquat Rafiq. Update on global epidemiology of viral hepatitis and preventive strategiesWorld Journal of Clinical Cases 2018; 6(13): 589-599 doi: 10.12998/wjcc.v6.i13.589
22
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the treatment of HIV-/HCV-coinfected patientsPharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
23
Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvirAlimentary Pharmacology & Therapeutics 2019; 49(1): 99 doi: 10.1111/apt.15043
24
Dongxian Ye, Yuqing Tang, Yuanliang Gu, Harris Haleem, Libo Zhang, Youping Zhang, Chunxia Xu, Jinshun Zhao. Evaluation of the effectiveness of a pilot study of hospital-based hepatitis C epidemic surveillanceMedicine 2019; 98(51): e18334 doi: 10.1097/MD.0000000000018334
25
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti. Discussion on critical points for a tailored therapy to cure hepatitis C virus infectionClinical and Molecular Hepatology 2019; 25(1): 30 doi: 10.3350/cmh.2018.0061
26
Kun Wei, Ben-Chun Jiang, Jing-Hui Guan, Dong-Na Zhang, Meng-Xuan Zhang, Jun-Long Wu, Guang-Ze Zhu. Decreased CD4+CD25+CD127dim/− Regulatory T Cells and T Helper 17 Cell Responsiveness to Toll-Like Receptor 2 in Chronic Hepatitis C Patients with Daclatasvir Plus Asunaprevir TherapyViral Immunology 2018; 31(8): 559 doi: 10.1089/vim.2018.0055